Create something meaningful

Two year program for inventors

SPARK supports scientists, students and clinicians by educating on drug and health tech discovery and development, and building the understanding of business aspects related to their discoveries.

spark_education
EDUCATION

“SPARK scholars and clinicians” (AKA ‘SPARKees’) must attend regular seminars and workshops that teach the process on how to develop a solution (drug, medical device, bioinformatics…) and what needs to be understood on commercial and financial aspects for exploiting the commercial value of the solution. These are open for everyone.

mentorship
MENTORSHIP

Teams and our selected mentors meet every second Tuesday at 5-7pm. Meetings are closed-door sessions requiring signing a NDA/CDA by participants. Each project team provides regular updates to mentor panel and receives feedback and advice how to increase the maturity of their solutions. Mentors are able to provide project-specific advice for each stage of the development.

spark_advising
ADVISING

For SPARKees we provide top-notch project specific advising, access to some of the core facilities, and assistance in creating partnerships with industry, financiers and other relevant stakeholders.

spark_funding
FUNDING

We are preparing an opportunity to provide milestone-based funding for maximum of two years. Each round of funding is contingent upon completion of the prior term goals.

Applying

Call for projects

Each year, an expert panel of faculty and industry advisors reviews proposals submitted from across the academic and clinical landscape. Finalists are invited to present to the panel before final selections are made.

Call for new projects is CLOSED.
Stay tuned for next OPEN call.
Selection criteria

Calls are targeted for wide spectrum in health tech and life science field; from dugs and vaccines to diagnostics and med tech – all the way to bioinformatics and healthIT.

The solution of the proposed project must:

  • address a clinical unmet need
  • utilize a novel approach (preferably with opportunity to IP)
  • have the potential to advance to clinic, clinical trials or commercialization within 2-3 years